GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » GF Value

HCAT (Health Catalyst) GF Value : $10.79 (As of Dec. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst GF Value?

As of today (2024-12-15), Health Catalyst's share price is $7.99. Health Catalyst's GF Value is $10.79. Therefore, Health Catalyst's Price-to-GF-Value for today is 0.74. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Health Catalyst is Modestly Undervalued.

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.


Health Catalyst  (NAS:HCAT) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Health Catalyst's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=7.99/10.79
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health Catalyst GF Value Related Terms

Thank you for viewing the detailed overview of Health Catalyst's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Catalyst Business Description

Traded in Other Exchanges
Address
10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Executives
Kevin Lee Freeman officer: Chief Growth Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Linda Llewelyn officer: Chief People Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Benjamin Landry officer: General Counsel C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Jason Alger officer: Chief Accounting Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton director, officer: Chief Executive Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Matthew Kolb director C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt officer: Chief Financial Officer C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore officer: COO and Chief Product Officer C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein officer: General Counsel 311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier officer: Chief Operating Officer C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton officer: Chief Technology Officer C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr. officer: Chief Financial Officer C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris director C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121